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A high intake of the omega-3 fatty acids has been associated with systemic anti-inflammatory effects and cardiovascular 
protection, but the molecular basis responsible for these effects remains incompletely defined. COX-2 is a proinflammatory 
enzyme the expression of which is increased in human atheroma. We here investigated the effects of DHA on COX-2 
expression in human saphenous vein endothelial cells (HSVEC) challenged with proinflammatory stimuli and explored the 
underlying molecular mechanisms. 
Methods and Results: A long-term (24-72 h) exposure of HSVEC to DHA (10-25 mmol/L) significantly reduced COX-2 
protein (by 50%, at Western analysis) and mRNA (by 70%, at Northern analysis) as induced by IL1α, through the attenuation 
of NF-kB activation (by 60%, at EMSA). Since protein kinase C (PKC), and NAD(P)H oxidase all participate in IL-1-mediated 
COX-2 expression, we tested whether these enzymatic activities were affected by DHA. Western analysis showed that DHA 
reduces the activation of NAD(P)H oxidase and PKC-e but not -α or -ζ. To address the question whether DHA itself or DHA-
derived products were responsible for these effects, we inhibited (by pharmacological and molecular approaches, siRNA) the 
most important enzymes involved in polyunsaturated fatty acid metabolism, showing that only the 15-LO-1 inhibition partially 
reverted the DHA inhibitory effect on COX-2 expression (by 30%, at Western analysis), thus suggesting that the 15-LO-1 
products mediate part of DHA effects. 
These data provide a mechanistic basis for antiinflammatory and possibly plaque-stabilizing effects of DHA. 
 
